401 related articles for article (PubMed ID: 10924969)
1. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.
Lapeyre M; Hoffstetter S; Peiffert D; Guérif S; Maire F; Dolivet G; Toussaint B; Mundt A; Chassagne JF; Simon C; Bey P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):37-42. PubMed ID: 10924969
[TBL] [Abstract][Full Text] [Related]
2. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins.
Lapeyre M; Bollet MA; Racadot S; Geoffrois L; Kaminsky MC; Hoffstetter S; Dolivet G; Toussaint B; Luporsi E; Peiffert D
Head Neck; 2004 Mar; 26(3):216-23. PubMed ID: 14999796
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome.
Zelefsky MJ; Harrison LB; Fass DE; Armstrong J; Spiro RH; Shah JP; Strong EW
Head Neck; 1990; 12(6):470-5. PubMed ID: 2258285
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.
Bachaud JM; Delannes M; Allouache N; Benchalal M; Alzieu C; David JM; Serrano E; Daly-Schveitzer NJ
Radiother Oncol; 1994 Jun; 31(3):199-206. PubMed ID: 8066202
[TBL] [Abstract][Full Text] [Related]
5. [Functional results succeeding primary combined external radiotherapy and brachytherapy for head and neck tumors].
Scheithauer M; Dohr D; Riechelmann H
Laryngorhinootologie; 2002 Oct; 81(10):712-7. PubMed ID: 12397521
[TBL] [Abstract][Full Text] [Related]
6. Challenging the Requirement to Treat the Contralateral Neck in Cases With >4 mm Tumor Thickness in Patients Receiving Postoperative Radiation Therapy for Squamous Cell Carcinoma of the Oral Tongue or Floor of Mouth.
O'steen L; Amdur RJ; Morris CG; Hitchcock KE; Mendenhall WM
Am J Clin Oncol; 2019 Jan; 42(1):89-91. PubMed ID: 30234502
[TBL] [Abstract][Full Text] [Related]
7. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.
Mazeron JJ; Simon JM; Le Péchoux C; Crook JM; Grimard L; Piedbois P; Le Bourgeois JP; Pierquin B
Radiother Oncol; 1991 May; 21(1):39-47. PubMed ID: 1852918
[TBL] [Abstract][Full Text] [Related]
8. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
[TBL] [Abstract][Full Text] [Related]
9. [Interstitial and percutaneous radiotherapy after limited surgery in carcinoma of the oral cavity].
Fietkau R; Grabenbauer GG; Iro H; Müller RG; Farmand M; Atendorf-Hofmann A; Sauer R
Strahlenther Onkol; 1991 Oct; 167(10):591-8. PubMed ID: 1948644
[TBL] [Abstract][Full Text] [Related]
10. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
11. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases.
Pernot M; Hoffstetter S; Peiffert D; Luporsi E; Marchal C; Kozminski P; Dartois D; Bey P
Radiother Oncol; 1995 Jun; 35(3):177-85. PubMed ID: 7480819
[TBL] [Abstract][Full Text] [Related]
12. T1 and T2 squamous cell carcinomas of the floor of the mouth: results of brachytherapy mainly using 198Au grains.
Matsumoto S; Takeda M; Shibuya H; Suzuki S
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):833-41. PubMed ID: 8598360
[TBL] [Abstract][Full Text] [Related]
13. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
[TBL] [Abstract][Full Text] [Related]
14. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue.
Mazeron JJ; Crook JM; Benck V; Marinello G; Martin M; Raynal M; Haddad E; Peynègre R; Le Bourgeois JP; Walop W
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1369-76. PubMed ID: 2262360
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
[TBL] [Abstract][Full Text] [Related]
16. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth.
Simon JM; Mazeron JJ; Pohar S; Le Péchoux C; Crook JM; Grimard L; Piedbois P; Le Bourgeois JP; Pierquin B
Radiother Oncol; 1993 Jan; 26(1):19-25. PubMed ID: 8438082
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
[TBL] [Abstract][Full Text] [Related]
18. High dose rate brachytherapy for early stage oral tongue cancer.
Leung TW; Wong VY; Kwan KH; Ng TY; Wong CM; Tung SY; Leung LC; O SK
Head Neck; 2002 Mar; 24(3):274-81. PubMed ID: 11891960
[TBL] [Abstract][Full Text] [Related]
19. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):137-48. PubMed ID: 9300748
[TBL] [Abstract][Full Text] [Related]
20. Resection margin as a predictor of recurrence at the primary site for T1 and T2 oral cancers. Evaluation of histopathologic variables.
van Es RJ; van Nieuw Amerongen N; Slootweg PJ; Egyedi P
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):521-5. PubMed ID: 8615970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
